Clinical trial · Interventional
Telemedicine Clinic for Prostate Cancer Patients
A Pilot Study of a Nurse and Pharmacist Led OTN (Ontario Telemedicine Network) Based Clinic for Management of Prostate Cancer Patients on Oral Therapy
NCT03413865CI-TRIAL-00037118unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Treatment-Related | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Visits conducted via Telemedicine | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- OTN virtual clinic
- description
- Pharmacist and nurse led OTN based remote teleconference based clinic (OTN) The OTN clinic will be conducted by providing the patient with a link via email which will allow the patient to access OTN teleconferencing and meet virtually with a pharmacist and nurse during a previously scheduled appointment. Virtual clinic appointments will be 30 minutes long and will consist of a patient assessment and open ended questions about the patient health status using a modified version of the validated MOATT (MASCC Oral Agent Teaching Tool) created by the Multidisciplinary Association of Supportive Care in Cancer.
- interventionNames
- Other: Visits conducted via Telemedicine
- type
- NO_INTERVENTION
- label
- In person Visits
- description
- Patients are followed in person at the cancer clinic based on standard of care guidelines
Primary outcomes (1)
- measure
- Patient satisfaction with overall care
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide. 2. Ability to provide consent to study. 3. Willingness to complete study questionnaires and a semi-structured exit interview. 4. Adequate command of the English language to complete study questionnaire and survey. 5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group) 6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group) Exclusion Criteria: 1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide. 2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group) \-
References
Publications (0)
Data not yet available
No reference posted for this study.